Investment3 Feb 2025, 09:20 pm
Cipla Ltd. to Invest Approx. ZAR 900 Million in Cipla Medpro South Africa Proprietary Limited
AI Summary
Cipla Ltd. will invest approximately ZAR 900 million in equity share capital of its wholly-owned subsidiary, Cipla Medpro South Africa Proprietary Limited (CMSA). The investment aims to reduce inter-group debt and improve the capital structure of CMSA and its subsidiaries. CMSA is involved in marketing, manufacturing, and supplying pharmaceutical products in South Africa. The transaction is a related party transaction and will be at arm's length. The investment is expected to be completed by 28th February 2025.
Key Highlights
- Cipla Ltd. to invest approx. ZAR 900 million in Cipla Medpro South Africa Proprietary Limited
- The investment aims to reduce inter-group debt and improve the capital structure of CMSA and its subsidiaries
- CMSA is involved in marketing, manufacturing, and supplying pharmaceutical products in South Africa
- The transaction is a related party transaction and will be at arm's length
- The investment is expected to be completed by 28th February 2025